Theravance Biopharma, Inc. (TBPH)
18.17
+0.49
(+2.77%)
USD |
NASDAQ |
Dec 12, 16:00
18.31
+0.14
(+0.77%)
After-Hours: 20:00
Theravance Biopharma EPS Diluted (TTM): 0.5625 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 0.8752 |
| Assertio Holdings, Inc. | -0.3142 |
| Skye Bioscience, Inc. | -1.290 |
| FibroGen, Inc. | 39.34 |
| VYNE Therapeutics, Inc. | -0.7887 |